Evaluation of combined therapeutic effects of hydrogen sulfide donor sodium hydrogen sulfide and phosphodiesterase type‐5 inhibitor tadalafil on erectile dysfunction in a partially bladder outlet obstructed rat model
- 9 March 2020
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 39 (4) , 1087-1097
Abstract
Aims: To evaluate the impacts of hydrogen sulfide (H2S) donor, sodium hydrogen sulfide (NaHS), and phosphodiesterase type‐5 inhibitor (PDE5i), tadalafil per se and their combination treatment on partial bladder outlet obstruction (PBOO)‐induced erectile dysfunction (ED).Methods: Sprague‐Dawley rats were equally divided into five groups: (a) sham‐operated control; (b) PBOO; (c) PBOO‐treated with NaHS (5.6 mg/kg/day, ip); (d) PBOO‐treated with tadalafil (2 mg/kg/day, oral); and (e) PBOO‐treated with combination of NaHS and tadalafil. The obstruction was created by urethral ligation for 6 weeks. In vivo erectile responses, in vitro relaxant and contractile responses in penile tissue as well as protein expression of nitric oxide synthases (NOS), H2S synthesis enzymes, oxidative stress, hypoxia, fibrosis markers, and the smooth muscle/collagen ratio and apoptosis were analyzed.Results: Combined treatment entirely returned increased bladder mass, reduced erectile responses, relaxation responses to acetylcholine, and electrical field stimulation in obstructed rats, while partial amelioration was observed after mono‐treatment. Decreased neuronal NOS and 3‐mercaptopiruvate transferase enzyme expressions in penile tissue from obstructed rats were also entirely restored by the combined treatment. Mono‐treatment partially improved increased hypoxia, oxidative stress, fibrosis markers, decreased smooth muscle mass, and H2S levels, while combined therapy completely recovered.Conclusions: The combination therapy with H2S donor and PDE5i had positive effects on erectile responses through the improvement of ischemia‐induced morphological and functional penile alterations in obstruction. H2S and NO may likely play a synergistic role in the regulation of erectile function and have constructive effects on clinical outcomes in male patients with ED and benign prostatic hyperplasia/lower urinary tract symptoms.Keywords
Funding Information
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (216S813)
This publication has 23 references indexed in Scilit:
- Bladder outlet obstruction triggers neural plasticity in sensory pathways and contributes to impaired sensitivity in erectile dysfunctionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2013
- Sildenafil Effect on the Human Bladder Involves the L-cysteine/Hydrogen Sulfide Pathway: A Novel Mechanism of Action of Phosphodiesterase Type 5 InhibitorsEuropean Urology, 2012
- Hydrogen Sulfide Stimulates Ischemic Vascular Remodeling Through Nitric Oxide Synthase and Nitrite Reduction Activity Regulating Hypoxia‐Inducible Factor‐1α and Vascular Endothelial Growth Factor–Dependent AngiogenesisJournal of the American Heart Association, 2012
- Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxationProceedings of the National Academy of Sciences, 2012
- Endogenous hydrogen sulfide insufficiency as a predictor of sexual dysfunction in aging ratsThe Aging Male, 2011
- Animal model for the study of the relationship between lower urinary tract symptoms/bladder outlet obstruction and erectile dysfunctionInternational Journal of Urology, 2011
- Increased penile expression of transforming growth factor and elevated systemic oxidative stress in rabbits with chronic partial bladder outlet obstructionInternational Journal of Andrology, 2011
- Hydrogen Sulfide Is an Endogenous Inhibitor of Phosphodiesterase ActivityArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Alfuzosin attenuates erectile dysfunction in rats with partial bladder outlet obstructionBJU International, 2008
- Investigative Urology: PGE sub 1 Suppresses the Induction of Collagen Synthesis by Transforming Growth Factor-beta sub 1 in Human Corpus Cavernosum Smooth MuscleJournal of Urology, 1995